• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov14
Anebulo Pharmaceuticals released FY2026 Q1 earnings on November 13 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.0525 (forecast USD -0.12)
04:00
Nov13
Anebulo Pharmaceuticals Inc. Receives NIH Funding for Research on Cannabis-Induced Toxicity in Children
21:06
Oct1
Anebulo Pharmaceuticals Advances Research on Cannabis Toxicity Treatment Drug
06:57
Sep30
Anebulo Pharmaceuticals released FY2025 Annual Earnings on September 29 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.2508 (forecast USD -0.285)
03:00
Anebulo Pharmaceuticals released FY2025 Q4 earnings on September 29 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.0522 (forecast USD -0.065)
03:00
May15
Maxim Group Maintains Buy Rating for Anebulo Pharmaceuticals But Cuts Price Target to $3.00
17:32

Schedules & Filings

Schedules
Filings
Nov13
Earning Release(EST)

FY2026 Q1 Earning Release (USD) Net Income -2.158 M, EPS -0.0525

Sep29
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Net Income -2.145 M, EPS -0.0522

May13
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -1.676 M, EPS -0.0407

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MGRT
11.340
+111.96%
+5.990
PCSA
5.800
+93.01%
+2.795
ATPC
0.1458
+62.00%
+0.056
VYNE
0.6467
+60.59%
+0.245
YCBD
2.223
+55.46%
+0.793
ISPO
4.165
+46.65%
+1.325
MDLN
39.350
+35.69%
+10.350
BENF
4.990
+33.42%
+1.250
GVH
3.925
+33.05%
+0.975
ANDG
20.870
+30.44%
+4.870
View More